HIGHLIGHTS
- who: Natalie Baker Campbell and colleagues from the Department of Anatomy and Neurobiology, Boston University Chobanian and Avedesian School of Medicine, Boston University, Boston, MA, USA have published the research: Extracellular Vesicle Treatment Alleviates Neurodevelopmental and Neurodegenerative Pathology in Cortical Spheroid Model of Down Syndrome, in the Journal: (JOURNAL)
- what: The authors evaluated the therapeutic effect of MSC-EVs in a cortical spheroid (CS) model of DS generated from patient-derived induced pluripotent stem cells (iPSCs). The gene dosage effect of Amyloid precursor protein (APP), one of the HAS21 genes, is considered one of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.